obviously part of what is different now in the hospitals, and even out patient setting compared to say a year ago when we were seeing huge numbers of a different kind and variant. one of the things that is different is the means that we have to treat people. we did just see this announcement that we re doubling the order for the new therapeutics the very promising pfizer antiviral pill. will we get it sooner? we ll get more. but access to significant numbers of doses of that medicine any faster? we ll get some sooner. supply is still very tight. in the near term. wheal have 200,000 courses this month and next we get to about 650,000 courses in march. by april we get to 2 million. in that month. that s when things open up. by june we ll have the first 10 million. september 20 million. the most important thing is in
icu. and that is very good news. it is good news and something i feel like i have seen sort of preliminary data and foreign data and everything hearing you put it in simple terms that is a significant thing. obviously, part of what is different now in the hospitals and even in outpatient setting compared to, say, a year ago, when we were seeing huge numbers of a different kind and a different variant, one of the things that s different is the means that we have to treat people. we did just see this announcement that we re doubling the order for the new therapeutics for the new very promising pfizer antiviral pill. i have to ask you, are we getting it any sooner? obviously, that means we ll get more in the end, but are we getting access to that dose faster? we re getting some sooner but
two weeks to help keep health care workers safe. we ve established free testing locations across the nation with additional new sites opening soon in maine, maryland, nevada, delaware, texas and washington state. we ve worked aggressively to s stock our nation s medicine cap net with a diverse portfolio of treatments. it s important to note that we have more treatments available now than at any point during the pandemic. yesterday the president announced he s instructed the team to double the u.s. government s purchase of the pfizer antiviral pill from 10 million treatment courses to 20 million. in addition, we re working with pfizer to accelerate the delivery of these pills and will now have the first 10 million treatment cycles, courses, by the end of june instead of the end of september. these pills can dramatically